Tracking outcomes of filovirus diseases in French hospitals
Part of Infections clinical trials.
This study follows patients who are hospitalized with a filovirus disease (like Ebola or Marburg) in France to better understand the disease's effects and outcomes over time. By joining, you help doctors learn how to improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of a filovirus disease, such as Ebola or Marburg.
- You are currently being treated in a recognized referral hospital in France.
- You cannot join if you or your legal representative do not sign the consent form.
- You cannot join if you are in custody or under a legal guardianship or protection order.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a bank of leftover blood and other samples from patients at two French hospitals. It helps researchers test new, faster ways to diagnose diseases.
This study tracks viruses that cause sudden colds and flu-like illnesses during winter months in France. Researchers collect information from patients seen by participating doctors to better understand which respiratory viruses are circulating and help prepare for future outbreaks.
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
This study follows people starting treatment for tuberculosis (TB) in France to learn more about the disease and its treatment. If you have been diagnosed with TB and started treatment within the last 8 days, you may be able to join.
This trial is a national hospital registry that collects information from people hospitalized with suspected infective endocarditis (an infection of the heart lining or valves). It may help doctors better classify cases and improve care by analyzing real-world patient data.
This study is looking at how to better care for people with fever in the Democratic Republic of the Congo. If you have a fever now or very recently, you may be able to join and help doctors learn more about it.
Hear when a new Filovirus Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.